265 related articles for article (PubMed ID: 24081307)
1. miR-34a expression, epigenetic regulation, and function in human placental diseases.
Doridot L; Houry D; Gaillard H; Chelbi ST; Barbaux S; Vaiman D
Epigenetics; 2014 Jan; 9(1):142-51. PubMed ID: 24081307
[TBL] [Abstract][Full Text] [Related]
2. Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia.
Chelbi ST; Mondon F; Jammes H; Buffat C; Mignot TM; Tost J; Busato F; Gut I; Rebourcet R; Laissue P; Tsatsaris V; Goffinet F; Rigourd V; Carbonne B; Ferré F; Vaiman D
Hypertension; 2007 Jan; 49(1):76-83. PubMed ID: 17088445
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseases.
Chelbi ST; Wilson ML; Veillard AC; Ingles SA; Zhang J; Mondon F; Gascoin-Lachambre G; Doridot L; Mignot TM; Rebourcet R; Carbonne B; Concordet JP; Barbaux S; Vaiman D
Hum Mol Genet; 2012 May; 21(9):1968-78. PubMed ID: 22246292
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-34a inhibits human trophoblast cell invasion by targeting MYC.
Sun M; Chen H; Liu J; Tong C; Meng T
BMC Cell Biol; 2015 Sep; 16():21. PubMed ID: 26335888
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.
Pang RT; Leung CO; Lee CL; Lam KK; Ye TM; Chiu PC; Yeung WS
BMC Cancer; 2013 Jan; 13():25. PubMed ID: 23327670
[TBL] [Abstract][Full Text] [Related]
6. From animal models to patients: the role of placental microRNAs, miR-210, miR-126, and miR-148a/152 in preeclampsia.
Frazier S; McBride MW; Mulvana H; Graham D
Clin Sci (Lond); 2020 Apr; 134(8):1001-1025. PubMed ID: 32337535
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-30a-3p is overexpressed in the placentas of patients with preeclampsia and affects trophoblast invasion and apoptosis by its effects on IGF-1.
Niu ZR; Han T; Sun XL; Luan LX; Gou WL; Zhu XM
Am J Obstet Gynecol; 2018 Feb; 218(2):249.e1-249.e12. PubMed ID: 29155142
[TBL] [Abstract][Full Text] [Related]
8. NFAT5 Is Up-Regulated by Hypoxia: Possible Implications in Preeclampsia and Intrauterine Growth Restriction.
Dobierzewska A; Palominos M; Irarrazabal CE; Sanchez M; Lozano M; Perez-Sepulveda A; Monteiro LJ; Burmeister Y; Figueroa-Diesel H; Rice GE; Illanes SE
Biol Reprod; 2015 Jul; 93(1):14. PubMed ID: 25995271
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-mRNA Networks in Pregnancy Complications: A Comprehensive Downstream Analysis of Potential Biomarkers.
Ali A; Hadlich F; Abbas MW; Iqbal MA; Tesfaye D; Bouma GJ; Winger QA; Ponsuksili S
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669156
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of STAT5A and its role as fetal DNA epigenetic marker during placental development and dysfunction.
Rahat B; Thakur S; Bagga R; Kaur J
Placenta; 2016 Aug; 44():46-53. PubMed ID: 27452437
[TBL] [Abstract][Full Text] [Related]
11. Elevated microRNA-34a contributes to trophoblast cell apoptosis in preeclampsia by targeting BCL-2.
Guo M; Zhao X; Yuan X; Li P
J Hum Hypertens; 2017 Dec; 31(12):815-820. PubMed ID: 29022890
[TBL] [Abstract][Full Text] [Related]
12. Regulatory effect of miR-195 in the placental dysfunction of preeclampsia.
Gunel T; Kamali N; Hosseini MK; Gumusoglu E; Benian A; Aydinli K
J Matern Fetal Neonatal Med; 2020 Mar; 33(6):901-908. PubMed ID: 30078346
[No Abstract] [Full Text] [Related]
13. Influence of miR-34a on preeclampsia through the Notch signaling pathway.
Liu JJ; Zhang L; Zhang FF; Luan T; Yin ZM; Rui C; Ding HJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):923-931. PubMed ID: 30779057
[TBL] [Abstract][Full Text] [Related]
14. Cullins in human intra-uterine growth restriction: expressional and epigenetic alterations.
Gascoin-Lachambre G; Buffat C; Rebourcet R; Chelbi ST; Rigourd V; Mondon F; Mignot TM; Legras E; Simeoni U; Vaiman D; Barbaux S
Placenta; 2010 Feb; 31(2):151-7. PubMed ID: 20005570
[TBL] [Abstract][Full Text] [Related]
15. Placental microRNAs in pregnancies with early onset intrauterine growth restriction and preeclampsia: potential impact on gene expression and pathophysiology.
Awamleh Z; Gloor GB; Han VKM
BMC Med Genomics; 2019 Jun; 12(1):91. PubMed ID: 31248403
[TBL] [Abstract][Full Text] [Related]
16. Analysis of polymorphisms, promoter methylation, and mRNA expression profile of maternal and placental P53 and P21 genes in preeclamptic and normotensive pregnant women.
Harati-Sadegh M; Kohan L; Teimoori B; Mehrabani M; Salimi S
J Biomed Sci; 2019 Nov; 26(1):92. PubMed ID: 31703578
[TBL] [Abstract][Full Text] [Related]
17. Potential pathophysiological role of microRNA 193b-5p in human placentae from pregnancies complicated by preeclampsia and intrauterine growth restriction.
Awamleh Z; Han VKM
Mol Biol Rep; 2020 Sep; 47(9):6531-6544. PubMed ID: 32803505
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic mechanisms regulate placental c-myc and hTERT in normal and pathological pregnancies; c-myc as a novel fetal DNA epigenetic marker for pre-eclampsia.
Rahat B; Hamid A; Ahmad Najar R; Bagga R; Kaur J
Mol Hum Reprod; 2014 Oct; 20(10):1026-40. PubMed ID: 25024139
[TBL] [Abstract][Full Text] [Related]
19. Differentially expressed microRNAs and affected biological pathways revealed by modulated modularity clustering (MMC) analysis of human preeclamptic and IUGR placentas.
Guo L; Tsai SQ; Hardison NE; James AH; Motsinger-Reif AA; Thames B; Stone EA; Deng C; Piedrahita JA
Placenta; 2013 Jul; 34(7):599-605. PubMed ID: 23639576
[TBL] [Abstract][Full Text] [Related]
20. Combination of promoter hypomethylation and PDX1 overexpression leads to TBX15 decrease in vascular IUGR placentas.
Chelbi ST; Doridot L; Mondon F; Dussour C; Rebourcet R; Busato F; Gascoin-Lachambre G; Barbaux S; Rigourd V; Mignot TM; Tost J; Vaiman D
Epigenetics; 2011 Feb; 6(2):247-55. PubMed ID: 20962579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
